The Demand for Outcomes Data
Assessment, interventions, and outcomes information is vital to specialty pharmacy stakeholders.
A Tribute to Oncology Nurses
Oncology nurses help improve patient outcomes through their dedication and expertise.
Trends in Cancer Care
With cancer ranking third among disease states in specialty spending, there is a growing emphasis on programs that focus on cost management and patient adherence to complex medication regimens.
Oncology Pharmacy: The Need for Specialization in Specialty Pharmacy
The complexities of cancer and the ever-changing medication regimens employed in its treatment call for the specialized competencies of oncology-focused pharmacies. High-touch care and oncology expertise can improve outcomes.
The Role of Independent Specialty Pharmacies in Product Commercialization
Pharmaceutical manufacturers are increasingly looking to independent specialty pharmacies to play a key role in the launch of new products, harnessing the power of the independents’ ability to devote time and resources to patient care.
Specialty Pharmacy–Specific URAC Standards
Preparation for URAC accreditation requires a careful review of a specialty pharmacy’s customer service, specialty drug management, operations, and patient management procedures.
Specialty Is Not Always Pharmacy
Selection of the right distribution model is of key importance in the launch of a specialty product, where each of the stakeholders has specific needs and requirements that must be met.
GI Cancers: Neuroendocrine Cancer Update
Clinical trial results show that several new combination therapies offer great promise for the treatment of challenging neuroendocrine tumors in the gastrointestinal area.
Gazyva by Genentech
Gazyva is a novel anti-CD20 monoclonal antibody approved, in combination with chlorambucil, for the treatment of previously untreated chronic lymphocytic leukemia patients.